US-UK drug deal could result in 229,000 excess deaths in England, analysis suggests

The brief

The NHS will have to divert £45bn from essential services to pay for new medicines under the terms of the UK-US trade deal agreed last December, leading to more than 200,000 avoidable deaths of patients, analysis has found. Ministers have defended the deal as a way of helping British drug exports to the US avoid tariffs, and giving patients in England access to potentially life-extending drugs that would otherwise be denied. But they have been accused of caving in to US demands to spend billions of pounds a year extra on drugs supplied to the NHS after pressure from Donald Trump. The potentially devastating impact on NHS care has also…